Limited survival benefit in patients diagnosed with glioblastoma post-2016: a SEER population based registry analysis
This population-based cohort demonstrated minimal change in survival for patients diagnosed with GBM before and after FDA approval of TTFs in 2015.
Authors
- Matthew Koshy (ORCID: https://orcid.org/0000-0001-6937-7058)
- Mark Korpics (ORCID: https://orcid.org/0000-0001-8449-2986)
- Shaurya Dhingra (ORCID: https://orcid.org/0000-0002-5327-7535)
Institutions
- University of Illinois Chicago (US)
- University of Illinois Hospital & Health Sciences System (US)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1007/s00432-025-06171-4
- Citations
- 6
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 9.75